By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verva Pharmaceuticals 

Menlo Park  California    U.S.A.
Phone: n/a Fax: n/a



Company News
Verva Pharmaceuticals Announces Grant of United States Patent for Type 2 Diabetes Therapy VVP808 and Results of Annual General Meeting 6/3/2013 9:35:05 AM
Verva Pharmaceuticals Announces Results of Successful VVP808-002 Phase 2 Clinical Trial in Type 2 Diabetes and Outcome of Annual General Meeting 6/6/2012 9:32:27 AM
Investment in Verva Pharmaceuticals by the Medical Research Commercialisation Fund (MRCF) 10/27/2011 9:36:31 AM
Verva Pharmaceuticals Announces Commencement of VVP808 Clinical Trial in Type 2 Diabetes 4/27/2010 1:29:41 PM
Verva Pharmaceuticals Announces License of Key FGFR Intellectual Property to Isis Pharmaceuticals, Inc. (ISIS) for the Treatment of Obesity and Other Diseases 8/20/2009 10:19:41 AM
Verva Pharmaceuticals Announces AUD 2M Financing and Results of Annual General Meeting 6/18/2009 10:59:11 AM
Verva Pharmaceuticals CEO an Invited Panelist at the GTCBIO 4th Annual Metabolic Diseases World Summit 10/31/2008 3:04:45 PM
Verva PharmaceuticalsScientific Collaborators Receive Australian Government Grant to Advance GES Diabetes Discovery Platform 10/27/2008 4:04:30 PM